The management of breakthrough cancer pain

British Journal of Nursing

Volumn 20, Issue 13, 2011, Pages 803-807

  Davies, Andrew N ^a  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

Breakthrough pain; Cancer; Pain; Treatment

Indexed keywords

EID: 79960445914     PISSN: 09660461     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjon.2011.20.13.803     Document Type: Article

References (23)

1. Bailey F, Farley A (2006) Oral opioid drugs. In: Davies A ed. Cancer-Related Breakthrough Pain. Oxford University Press, Oxford: 43-55
2. Coluzzi PH, Schwartzberg L, Conroy Jr JD et al (2001) Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain 91(1-2):123-30 (Pubitemid 32274181)
3. Dale O (2006) Opioid drugs via other routes. In: Davies A ed. Cancer-Related Breakthrough Pain. Oxford University Press, Oxford: 73-82
4. Davies AN, Vriens J (2005) Oral transmucosal fentanyl citrate and xerostomia (dry mouth). J Pain Symptom Manage 30(6):496-7 (Pubitemid 41821200)
5. Davies A (2009). Why oral morphine is not the 'gold standard' for BTcP. Eur J Palliat Care 16(suppl):10-2
6. Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G (2009) The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 13(4):331-8 Epub
7. Davies A (2010) Breakthrough pain is often poorly controlled in patients with cancer. Guidelines in Practice 13(4):37-40
8. Enting RH, Oldenmenger WH, van der Rijt CC et al (2002) A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids. Cancer 94(11):3049-56 (Pubitemid 34547707)
9. Fine PG, Busch MA (1998) Characterization of breakthrough pain by hospice patients and their caregivers. J Pain Symptom Manage 16(3):179-83 (Pubitemid 28429066)
10. Hanks G W, Conno F, Cherny N et al (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84(5):587-93 (Pubitemid 32238990)
11. Hwang SS, Chang V T, Kasimis B (2003) Cancer breakthrough pain characteristics and responses to treatment at a VA medical center. Pain 101(1-2):55-64 (Pubitemid 36044654)
12. Kalso E, Heiskanen T, Rantio M, Rosenberg PH, Vainio A (1996) Epidural and subcutaneous morphine in the management of cancer pain: a double-blind cross-over study. Pain 67(2-3):443-9 (Pubitemid 26375362)
13. Mercadante S, Villari P, Ferrera P, Casuccio A (2004) Optimization of opioid therapy for preventing incident pain associated with bone metastases. J Pain Symptom Manage 28(5):505-10 (Pubitemid 39422489)
14. Mercadante S, Radbruch L, Davies A et al (2009) A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial. Curr Res Med Opin 25(11):2805-15
15. Petzke F, Radbruch L, Zech D, Loick G, Grond S (1999) Temporal presentation of chronic cancer pain: transitory pains on admission to a multidisciplinary pain clinic. J Pain Symptom Manage 17(6):391-401 (Pubitemid 29289765)
16. Portenoy RK (1997) Treatment of temporal variations in chronic cancer pain. Semin Oncol 5(16 suppl):S16-7-12
17. Portenoy RK, Burton AW, Gabrail N, Taylor D (2010) A multicenter, placebocontrolled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain. Pain 151(3):617-24 Epub
18. Rauck RL, Tark M, Reyes E et al (2009) Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain. Curr Med Res Opin 25(12):2877-85
19. Rauck R, North J, Gever LN, Tagarro I, Finn AL (2010) Fentanyl buccal soluble film (FBSF) for breakthrough pain in patients with cancer: a randomized, double-blind, placebo-controlled study. Ann Oncol 21(6):1308-14 Epub
20. Slatkin NE, Xie F, Messina J, Segal TJ (2007) Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain. J Support Oncol 5(7):327-34 (Pubitemid 350055013)
21. Swanwick M, Haworth M, Lennard RF (2001) The prevalence of episodic pain in cancer: a survey of hospice patients on admission. Palliat Med 15(1):9-18 (Pubitemid 32103353)
22. Walker G, Wilcock A, Manderson C, Weller R, Crosby V (2003) The acceptability of different routes of administration of analgesia for breakthrough pain. Palliat Med 17(2):219-21 (Pubitemid 36432601)
23. Zeppetella G (2010) Breakthrough pain. In: Hanks G, Cherny NI, Christakis NA, Fallon M, Kaasa S, Portenoy RK eds. Oxford Textbook of Palliative Medicine. 4th edn. Oxford University Press, Oxford: 654-61